Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
JAMA Neurology
|
March 16, 2026
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial
Merit Cudkowicz, Vivian E Drory, Adriano Chio, et al.
Muscle & Nerve
|
June 6, 2025
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02)
Jeffrey Rothstein, Angela Genge, Shari De Silva, et al.
Neurology
|
January 23, 2024
Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the <i>TARDBP</i> Pathogenic Variant
Cristina Moglia, Andrea Calvo, Antonio Canosa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 29, 2021
GBA variants influence cognitive status in amyotrophic lateral sclerosis
Antonio Canosa, Maurizio Grassano, Cristina Moglia, et al.
Neurology. Genetics
|
September 15, 2022
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis
Maurizio Grassano, Giorgia Brodini, Giovanni De Marco, et al.
BMJ Open
|
June 2, 2019
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
Jessica Mandrioli, Valeria Crippa, Cristina Cereda, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
February 27, 2010
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C Ludolph, Caterina Bendotti, Eran Blaugrund, et al.
Human Molecular Genetics
|
February 4, 2017
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten
Matthew J Stopford, Adrian Higginbottom, Guillaume M Hautbergue, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 25, 2022
Exploring the phenotype of Italian patients with ALS with intermediate <i>ATXN2</i> polyQ repeats
Adriano Chio, Cristina Moglia, Antonio Canosa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 10, 2020
TRICALS: creating a highway toward a cure
Ruben P A van Eijk, Tessa Kliest, Christopher J McDermott, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
JAMA Neurology
|
March 16, 2026
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial
Merit Cudkowicz, Vivian E Drory, Adriano Chio, et al.
Muscle & Nerve
|
June 6, 2025
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02)
Jeffrey Rothstein, Angela Genge, Shari De Silva, et al.
Neurology
|
January 23, 2024
Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the <i>TARDBP</i> Pathogenic Variant
Cristina Moglia, Andrea Calvo, Antonio Canosa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 29, 2021
GBA variants influence cognitive status in amyotrophic lateral sclerosis
Antonio Canosa, Maurizio Grassano, Cristina Moglia, et al.
Neurology. Genetics
|
September 15, 2022
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis
Maurizio Grassano, Giorgia Brodini, Giovanni De Marco, et al.
BMJ Open
|
June 2, 2019
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
Jessica Mandrioli, Valeria Crippa, Cristina Cereda, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
February 27, 2010
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C Ludolph, Caterina Bendotti, Eran Blaugrund, et al.
Human Molecular Genetics
|
February 4, 2017
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten
Matthew J Stopford, Adrian Higginbottom, Guillaume M Hautbergue, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 25, 2022
Exploring the phenotype of Italian patients with ALS with intermediate <i>ATXN2</i> polyQ repeats
Adriano Chio, Cristina Moglia, Antonio Canosa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 10, 2020
TRICALS: creating a highway toward a cure
Ruben P A van Eijk, Tessa Kliest, Christopher J McDermott, et al.
Page
of 8